Associated Papers
Long-term progression-free survival with first-line pyrotinib monotherapy in a treatment-naïve stage IV NSCLC patient harboring an ERBB2 exon 20 insertion: a case report.
Ke Z et al.
Frontiers in Oncology, 2025
Select a paper to view details